Histoid leprosy: A retrospective study of 40 cases from India

British Journal of Dermatology

Volumn 160, Issue 2, 2009, Pages 305-310

  Kaur, I ^a   Dogra, S ^a   De, D ^a   Saikia, U N ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Clinical features; Epidemiology; Histoid leprosy; Review; Treatment

Indexed keywords

DAPSONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; ERYTHEMA NODOSUM LEPROSUM; FEMALE; HISTOID LEPROSY; HUMAN; INCIDENCE; INDIA; LEPROMATOUS LEPROSY; LEPROSY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; ERYTHEMA NODOSUM; FEMALE; HUMANS; INCIDENCE; INDIA; LEPROSTATIC AGENTS; LEPROSY, LEPROMATOUS; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 58349089461     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08899.x     Document Type: Article

References (35)

1. World Health Organization. Global leprosy situation, 2007. Weekly Epidemiological Records 2007 82 : 225 32. Available at: http://www.who.int/wer/ 2007/wer8225.pdf (last accessed 22 July 2007).
2. Announcement: India achieves national elimination of leprosy. Indian J Lepr 2006 78 : 101.
3. Wade HW. The histoid leproma. Int J Lepr Other Mycobact Dis 1960 28 : 469 Abstract).
4. Sehgal VN, Srivastava G. Histoid leprosy: a prospective diagnostic study in 38 patients. Dermatologica 1988 177 : 212 17.
5. Singh VV, Singh G, Kaur P, Pandey SS. Histoid leprosy in Varanasi. Indian J Dermatol Venereol Leprol 1983 49 : 160 1.
6. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966 34 : 255 73.
7. WHO Expert Committee on Leprosy. Sixth Report. World Health Organ Tech Rep Ser 1988 768 : 1 51.
8. WHO Expert Committee on Leprosy. Seventh report. World Health Organ Tech Rep Ser 1998 874 : 1 43.
9. Sehgal VN, Srivastava G. Status of histoid leprosy - a clinical, bacteriological, histopathological and immunological appraisal. J Dermatol 1987 14 : 38 42.
10. Wade HW. The histoid variety of lepromatous leprosy. Int J Lepr 1963 31 : 129 42.
11. WHO Study Group. Chemotherapy of leprosy for control programmes. World Health Organ Tech Rep Ser 1982 675 : 1 33.
12. WHO Study Group. Chemotherapy of leprosy. World Health Organ Tech Rep Ser 1994 847 : 1 24.
13. Crocos MG, Crocos CD. 'Tuberculoid contamination' in histoid hanseniasis. Int J Lepr Other Mycobact Dis 1994 62 : 301 5.
14. Malik R, Khandpur R, Chandra K, Singh R. A clinico-pathological study of 244 cases of leprosy with special reference to histoid variety. Lepr India 1977 43 : 400 5.
15. Salodkar AD, Kalla G. A clinico-epidemiological study of leprosy in arid north-west Rajasthan, Jodhpur. Indian J Lepr 1995 67 : 161 6.
16. Kalla G, Purohit S, Vyas MC. Histoid, a clinical variant of multibacillary leprosy: report from so-called nonendemic areas. Int J Lepr Other Mycobact Dis 2000 68 : 267 71.
17. Price EW, Fitzherbert M. Histoid (high-resistance) lepromatous leprosy. Int J Lepr Other Mycobact Dis 1966 34 : 367 74.
18. Ramos-Caro FA. Histoid lepromas. Cutis 1982 30 : 108 9.
19. Shaw IN, Ebenezer G, Rao GS et al. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases. Int J Lepr Other Mycobact Dis 2000 68 : 272 6.
20. Kamath HD, Sukumar D, Shetty NJ, Nanda KB. Giant lesions in histoid leprosy - an unusual presentation. Indian J Lepr 2004 76 : 355 8.
21. Kontochristopoulos GJ, Aroni K, Panteleos DN, Tosca AD. Immunohistochemistry in histoid leprosy. Int J Dermatol 1995 34 : 777 81.
22. de Waal Malefyt R, Haanen J, Spits H et al. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991 174 : 915 24.
23. Sieling PA, Abrams JS, Yamamura M et al. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol 1993 150 : 5501 10.
24. Sehgal VN, Srivastava G. Histoid leprosy. Int J Dermatol 1985 24 : 286 92.
25. Shivaswamy KN, Thappa DM, Laxmisha C. Scrotal sinuses in histoid leprosy. Indian J Lepr 2004 76 : 231 2.
26. Thappa DM, Karthikeyan K, Vijaikumar M, Laxmisha C. Histoid leprosy masquerading as tuberous xanthomas. Indian J Lepr 2001 73 : 353 8.
27. Mohan L, Bhatia PS, Nigam P et al. Molluscum contagiosum type lesions in histoid leprosy. J Indian Med Assoc 1992 90 : 106.
28. Sehgal VN. Spontaneous appearances of papules, nodules, and/or plaques: a prelude to abacillary, paucibacillary, or multibacillary histoid leprosy. Skinmed 2006 5 : 139 41.
29. Kumar V, Mendiratta V, Sharma RC et al. Erythema nodosum leprosum in histoid leprosy: a case report. J Dermatol 1997 24 : 611 14.
30. Kaur S, Dhar S, Sharma VK, Ray R. Erythema nodosum leprosum in case of histoid leprosy. Int J Lepr Other Mycobact Dis 1993 61 : 292 3.
31. Sehgal VN, Gautam RK, Srivastava G et al. Erythema nodosum leprosum (ENL) in histoid leprosy. Indian J Lepr 1985 57 : 346 9.
32. Sharma P, Kar HK, Misra RS et al. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine. Int J Lepr Other Mycobact Dis 1999 67 : 259 69.
33. Vora NS, Vora VN, Mukhopadhyay AK et al. A case of histoid leprosy responding to ofloxacin along with standard MDT. Indian J Lepr 1995 67 : 183 6.
34. Mahajan PM, Jadhav VH, Mehta JM. Pefloxacin in histoid leprosy. Int J Lepr Other Mycobact Dis 1994 62 : 297 8.
35. Palit A, Inamadar AC. Histoid leprosy as reservoir of the disease; a challenge to leprosy elimination. Lepr Rev 2007 78 : 47 9.